Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Pediatric Population - Contacts and Locations

Home

Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Pediatric Population

This study has been completed.

Study NCT00071448. Last updated on November 27, 2008. Information provided by Novo Nordisk

Please refer to this study by its ClinicalTrials.gov identifier: NCT00071448

Locations


United States, New Jersey
	Novo Nordisk Clinical Trial Call Center
	Princeton, New Jersey, United States, 08540

Sponsors and Collaborators

Novo Nordisk

Investigators


Study Director:	Paula Hale, MD	Novo Nordisk